FCGR3B and alkaline phosphatase measurement: We find parallels between reduced numbers of CD14++CD16+ intermediate monocytes in patients with AP and AAH, and reduced numbers CD14++CD16+ cells following ex vivo treatment of PBMCs with different inflammatory mediators.